Rocket Doctor AI Inc

As of June 30, 2026, Rocket Doctor AI Inc carries a market capitalization of 57.47M, placing it among publicly traded companies globally. Its enterprise value stands at 57.72M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Rocket Doctor AI Inc's next confirmed earnings release is scheduled for December 1, 2026.

As of June 30, 2026, Rocket Doctor AI Inc has 97.41M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 18.33, and the price-to-book ratio stands at 159.84.

These figures are as of June 30, 2026. The EV/Sales ratio of 21.40 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 57.72M versus a market cap of 57.47M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Rocket Doctor AI Inc maintains a current ratio of 0.12, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 332.80, indicating elevated leverage, while an interest coverage ratio of -166.70 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Rocket Doctor AI Inc posted a negative return on equity (ROE) of -524.83, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -154.36, reflecting losses generated across the asset base. The company generates approximately 93,020.48 in revenue per employee across its workforce of 29.00, a quick read on workforce productivity versus industry peers.

As of the close on October 20, 2026, Rocket Doctor AI Inc's stock has declined approximately 36.00% over the past 52 weeks. The 50-day moving average sits at 0.60, while the 200-day moving average is 0.69.

Over the twelve months ended June 30, 2026, Rocket Doctor AI Inc generated 2.70M in revenue and converted that into -22.17M in net income, yielding earnings per share of -0.26. EBITDA reached -16.75M, while operating income came in at -19.45M.

As of June 30, 2026, Rocket Doctor AI Inc holds 947,653.00 in cash and equivalents against 1.20M in total debt, resulting in a net debt position of 248,993.00. Total book value stands at 359,574.00, with working capital of -8.48M providing operational flexibility.

Rocket Doctor AI Inc produced -10.00M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -23,724.00 in capital expenditures, free cash flow totaled -10.03M - equivalent to -0.12 per share.

Over the twelve months ended June 30, 2026, Rocket Doctor AI Inc posted a gross margin of 77.10, reflecting its pricing power and cost economics. The operating margin of -721.11 and net profit margin of -821.77 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -20.28: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -19.14, meaning Rocket Doctor AI Inc raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Rocket Doctor AI Inc's most recent stock split took place on July 24, 2023 with a 10:1 split ratio.

As of June 30, 2026, Rocket Doctor AI Inc has an Altman Z-Score of -129.84, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.